|
1
|
González CA, Sala N and Rokkas T: Gastric
cancer: Epidemiologic aspects. Helicobacter. 18 Suppl 1:S34–S38.
2013. View Article : Google Scholar
|
|
2
|
Wadhwa R, Song S, Lee JS, Yao Y, Wei Q and
Ajani JA: Gastric cancer-molecular and clinical dimensions. Nat Rev
Clin Oncol. 10:643–655. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peleteiro B, Bastos A, Ferro A and Lunet
N: Prevalence of Helicobacter pylori infection worldwide: A
systematic review of studies with national coverage. Dig Dis Sci.
59:1698–1709. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boyd MT, Vlatkovic N and Haines DS: A
novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest
that is suppressed by MDM2. J Biol Chem. 275:31883–31890. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iwakuma T, Tochigi Y, Van Pelt CS,
Caldwell LC, Terzian T, Parant JM, Chau GP, Koch JG, Eischen CM and
Lozano G: Mtbp haploinsufficiency in mice increases tumor
metastasis. Oncogene. 27:1813–1820. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vlatković N, El-Fert A, Devling T,
Ray-Sinha A, Gore DM, Rubbi CP, Dodson A, Jones AS, Helliwell TR,
Jones TM and Boyd MT: Loss of MTBP expression is associated with
reduced survival in a biomarker-defined subset of patients with
squamous cell carcinoma of the head and neck. Cancer.
117:2939–2950. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brady M, Vlatkovic N and Boyd MT:
Regulation of p53 and MDM2 activity by MTBP. Mol Cell Biol.
25:545–553. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iwakuma T and Lozano G: MDM2, an
introduction. Mol Cancer Res. 1:993–1000. 2003.PubMed/NCBI
|
|
12
|
Marine JC and Lozano G: Mdm2-mediated
ubiquitylation: p53 and beyond. Cell Death Differ. 17:93–102. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carson DA and Lois A: Cancer progression
and p53. Lancet. 346:1009–1011. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lane DP: Cancer. p53, guardian of the
genome. Nature. 358:15–16. 1992. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vassilev LT: p53 Activation by small
molecules: Application in oncology. J Med Chem. 48:4491–4499. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hollstein M, Sidransky D, Vogelstein B and
Harris CC: p53 mutations in human cancers. Science. 253:49–53.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hainaut P and Hollstein M: p53 and human
cancer: The first ten thousand mutations. Adv Cancer Res.
77:81–137. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumors. 7th. Wiley-Liss; New
York, NY: 2009
|
|
19
|
Borrmann R: Geschwülste des Magens und
DuodenumsVerdauungsschlauch. Erster Teil Rachen und Tonsillen,
Speiseröhre Magen und Darm, Bauchfell. Borchardt H, Borrmann R,
Christeller E, et al: Vienna: Springer; pp. 812–1054. 1926
|
|
20
|
Sano T and Aiko T: New Japanese
classifications and treatment guidelines for gastric cancer:
Revision concepts and major revised points. Gastric Cancer.
14:97–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Simon R, Mirlacher M and Sauter G: Tissue
microarrays. Biotechniques. 36:98–105. 2004.PubMed/NCBI
|
|
22
|
Zhou Z, Chen ZW, Yang XH, Shen L, Ai XH,
Lu S and Luo QQ: Establishment of a biomarker model for predicting
bone metastasis in resected stage III non-small cell lung cancer. J
Exp Clin Cancer Res. 31:342012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma Q, Li P, Xu M, Yin J, Su Z, Li W and
Zhang J: Ku80 is highly expressed in lung adenocarcinoma and
promotes cisplatin resistance. J Exp Clin Cancer Res. 31:992012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fan C, Miao Y, Zhang X, Liu D, Jiang G,
Lin X, Han Q, Luan L, Xu Z and Wang E: Btbd7 contributes to reduced
E-cadherin expression and predicts poor prognosis in non-small cell
lung cancer. BMC Cancer. 14:7042014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ji K, Ye L, Ruge F, Hargest R, Mason MD
and Jiang WG: Implication of metastasis suppressor gene, Kiss-1 and
its receptor Kiss-1R in colorectal cancer. BMC Cancer. 14:7232014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alam MJ, Fatima N, Devi GR Ravins and
Singh RK: The enhancement of stability of p53 in MTBP induced
p53-MDM2 regulatory network. Biosystems. 110:74–83. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Agarwal N, Adhikari AS, Iyer SV,
Hekmatdoost K, Welch DR and Iwakuma T: MTBP suppresses cell
migration and filopodia formation by inhibiting ACTN4. Oncogene.
32:462–470. 2013. View Article : Google Scholar : PubMed/NCBI
|
